What is the current Modafinil Tablets market size?

The Modafinil Tablets market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Modafinil Tablets market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driving future outlook.

What are the key drivers of the Modafinil Tablets market?

Increasing demand for cognitive enhancers and rising awareness of sleep disorders are key drivers.

What are the major challenges facing the Modafinil Tablets market?

Stringent regulatory requirements and potential side effects are major challenges.

Which regions are leading the Modafinil Tablets market?

North America and Europe are regional leaders, driven by high demand and strong distribution networks.

Who are the top companies in the Modafinil Tablets market?

Top companies include Teva Pharmaceutical and Mylan, with strong product portfolios and market presence.

What future opportunities exist in the Modafinil Tablets market?

Emerging markets and growing demand for non-traditional applications offer future opportunities.

How is technology impacting the Modafinil Tablets market?

Advances in manufacturing and digital healthcare are improving production efficiency and patient outcomes.

What is the current regulatory landscape for the Modafinil Tablets market?

The market is subject to strict regulations, including FDA and EMA guidelines, ensuring safety and efficacy.

What Is the Global Modafinil Tablets Market Worth in 2026?

Modafinil Tablets by Application (Narcolepsy, Obstructive Sleep Apnea, Shift Work Sleep Disorder, Other), by Types (100mg per Tablet, 200mg per Tablet), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 83

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 4.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 83

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 4.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Modafinil Tablets Market Size | CAGR 4.2 Forecast 2033

What Is the Global Modafinil Tablets Market Worth in 2026?

🏭 Healthcare🌍 Global

Pages: 83

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 4.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 83

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 4.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Modafinil Tablets Market Overview

The Modafinil Tablets market refers to the global industry involved in the production and distribution of Modafinil Tablets, a prescription medication used to treat sleep disorders such as narcolepsy, shift work sleep disorder, and obstructive sleep apnea. As the Modafinil Tablets market size is projected to experience significant growth, driven by an increasing awareness of sleep disorders and a rising demand for effective treatments, the growth outlook and market forecast are crucial for industry stakeholders. The industry expansion is expected to be fueled by advancements in technology, changes in regulations, and shifting consumer behaviors, making it essential for companies to stay informed about the latest trends and developments in the Modafinil Tablets market. The current Modafinil Tablets market size is approximately $1.4 billion, with the global market expected to grow at a CAGR of 8.5% from 2026 to 2033.

Loading chart…

The Modafinil Tablets market is driven by several key forces, including technology shifts towards more efficient and cost-effective production methods, regulations governing the use and distribution of prescription medications, and consumer behavior trends towards greater awareness and treatment of sleep disorders. The largest region in the Modafinil Tablets market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by increasing demand for effective treatments and a growing awareness of sleep disorders. As the market continues to evolve, companies must stay informed about the latest trends and developments to remain competitive and capitalize on emerging opportunities.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.67 billion
Growth rate	CAGR of 4.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Cephalon; Aurobindo Pharma; Apotex; Sun Pharmaceutical; Watson Labs; Orbion Pharmaceuticals; Zydus; Alembic Pharma
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Modafinil Tablets market is poised for significant growth, driven by increasing demand for cognitive enhancers and rising awareness about sleep disorders. Key dynamics shaping the market landscape include growth drivers, restraints, opportunities, and challenges that will influence the Modafinil Tablets market size and growth forecast.

Growth Drivers2 items

Growing prevalence of sleep disorders, such as narcolepsy and shift work sleep disorder, is driving the demand for Modafinil Tablets as a treatment option, thereby fueling market growth.

Increasing adoption of Modafinil Tablets in the treatment of attention deficit hyperactivity disorder (ADHD) and other neurological disorders is also contributing to the market's expansion.

Restraints2 items

Stringent regulatory requirements and the need for prescription to purchase Modafinil Tablets are limiting the market's growth potential, particularly in regions with strict healthcare regulations.

Side effects associated with Modafinil Tablets, such as headaches and nausea, may also hinder market growth as consumers become increasingly aware of the potential risks.

Opportunities2 items

The rising trend of Modafinil Tablets being used as a cognitive enhancer among students and working professionals presents a significant opportunity for market players to capitalize on this demand.

Growing investments in research and development to improve the efficacy and safety of Modafinil Tablets will also create new opportunities for market expansion and growth.

Challenges2 items

The presence of generic versions of Modafinil Tablets in the market poses a significant challenge to branded drug manufacturers, as it may lead to a decline in sales and revenue.

Fluctuations in the global economy and macroeconomic factors, such as changes in government policies and regulations, may also impact the Modafinil Tablets market size and growth forecast.

Market Segmentation

Loading chart…

The Modafinil Tablets market can be segmented based on Application, which includes subtypes such as narcolepsy, sleep apnea, shift work sleep disorder, and others. This segmentation contributes to the overall market size by providing insights into the specific uses of Modafinil Tablets. The Modafinil Tablets segmentation by application helps in understanding the demand for the product in different therapeutic areas.

Another key segment in the Modafinil Tablets market is Types, which includes subtypes such as branded and generic. This segmentation is crucial in determining the market share of different types of Modafinil Tablets. The market taxonomy of Modafinil Tablets by types helps in analyzing the competitive landscape and pricing strategies of various manufacturers.

Modafinil Tablets Segmentation Breakdown8 items

Application

Narcolepsy

Obstructive Sleep Apnea

Shift Work Sleep Disorder

Other

Types

100mg per Tablet

200mg per Tablet

Regional Insights

Loading chart…

The Modafinil Tablets market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the global market, driven by increasing adoption of Modafinil Tablets, favorable policies, and significant investments in healthcare infrastructure. The region's large population, rising demographics, and growing ecosystem maturity are also key drivers.

On the other hand, Latin America is expected to be the fastest-growing region, with a growth rate driven by increasing infrastructure development, improving ecosystem maturity, and rising demand for Modafinil Tablets. North America and Europe are also expected to contribute significantly to the Modafinil Tablets market growth, driven by high adoption rates, well-established policies, and significant investments in research and development.

The Middle East & Africa region is expected to experience steady growth, driven by increasing demand for Modafinil Tablets, improving infrastructure, and growing ecosystem maturity. Overall, the regional forecast indicates a positive outlook for the Modafinil Tablets market, with each region presenting unique opportunities and challenges.

Competitive Landscape

The Modafinil Tablets market is moderately consolidated, driven by a mix of global players and local/regional companies. Key competitive levers in this market include pricing, distribution, product innovation, certifications, and regulatory approvals. The Modafinil Tablets competitive landscape is characterized by high competition, with companies focusing on these levers to gain market share.

Common strategies employed by companies in this market include M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. The following companies are notable players in the market:

Cephalon: regional expansion

Aurobindo Pharma: vertical integration

Apotex: premium pricing

Sun Pharmaceutical: OEM tie-ups

Watson Labs: innovation pipeline

Orbion Pharmaceuticals: local manufacturing

Key Modafinil Tablets Companies8 items

Cephalon

Aurobindo Pharma

Apotex

Sun Pharmaceutical

Watson Labs

Orbion Pharmaceuticals

Zydus

Alembic Pharma

Market Ecosystem

The Modafinil Tablets ecosystem spans upstream, midstream, and downstream activities, encompassing technology providers, integrators, channels, and end users. This ecosystem is characterized by the creation and capture of value through the development, manufacturing, and distribution of Modafinil Tablets. The boundaries of this ecosystem are defined by the interactions between these participants, from raw material suppliers to end users, and the flow of value through the Modafinil Tablets ecosystem.

Raw material suppliers — provide active pharmaceutical ingredients

OEMs / manufacturers — produce Modafinil Tablets

Distributors / channel partners — deliver products to end users

Regulators/standards bodies — establish safety and efficacy standards

Service providers / after-sales — offer support and maintenance services

End users / buyers — consume Modafinil Tablets for therapeutic purposes

Data/analytics providers — provide insights on usage and efficacy

The flow of value through the Modafinil Tablets ecosystem is influenced by control points, such as regulatory approvals and standards, which can impact adoption and availability. Dependency risks, including input constraints and standards compliance, can also affect the ecosystem. Furthermore, switching costs, partnerships, and interoperability requirements can influence the relationships between participants. The ecosystem may differ by region due to variations in regulatory frameworks, market demands, and participant interactions, highlighting the need for a nuanced understanding of the value chain analysis to navigate these complexities.

Recent Industry Insights

The Modafinil Tablets industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between pharmaceutical companies have focused on expanding distribution networks and enhancing research capabilities. Notable mergers and acquisitions have also taken place, aiming to consolidate market share and improve product portfolios. Furthermore, several companies have launched new products or technologies, such as extended-release formulations, to cater to evolving consumer preferences and needs. Regulatory changes, including updated guidelines for prescription and usage, have also impacted the industry. Additionally, there has been a notable shift in consumer trends, with increasing demand for generic and affordable versions of Modafinil Tablets, driving companies to invest in manufacturing capabilities and explore new markets.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Modafinil Tablets market. The market attractiveness is moderate, driven by increasing demand for cognitive enhancement and wakefulness treatments. The competitive intensity is high, with multiple players competing for market share. The long-term outlook for the Modafinil Tablets market outlook is positive, with expected growth in the pharmaceutical industry. Innovation in drug formulation and delivery mechanisms is expected to shape the innovation landscape. However, the demand–supply balance may be affected by regulatory changes and key risk factors, such as patent expirations and generic competition.

11 items

1. Executive Summary

2. Modafinil Tablets Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Modafinil Tablets Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Modafinil Tablets Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Narcolepsy

6.1.2. Obstructive Sleep Apnea

6.1.3. Shift Work Sleep Disorder

6.1.4. Other

6.2. Global Modafinil Tablets Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. 100mg per Tablet

6.2.2. 200mg per Tablet

6.3. Global Modafinil Tablets Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Modafinil Tablets Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Modafinil Tablets Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Modafinil Tablets Market Competition by Key Manufacturers

8.1. Global Modafinil Tablets Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Modafinil Tablets: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Cephalon

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Aurobindo Pharma

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Apotex

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Sun Pharmaceutical

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Watson Labs

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Orbion Pharmaceuticals

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Zydus

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Alembic Pharma

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Modafinil Tablets Market

Figure 4: Global Modafinil Tablets Market: Drivers

Figure 5: Global Modafinil Tablets Market: Challenges

Figure 6: Global Modafinil Tablets Market: Trends

Figure 7: Global Modafinil Tablets Market: Opportunity

Figure 8: Global Modafinil Tablets Market: Restraint

Figure 9: Global Modafinil Tablets Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Modafinil Tablets Market Value (USD Million) By Region

Figure 15: Global Modafinil Tablets Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Modafinil Tablets Market Value (USD Million) By Region

Figure 23: Global Modafinil Tablets Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

69 items

Table 1: Market Segmentation Analysis

Table 2: Global Modafinil Tablets Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Modafinil Tablets Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Modafinil Tablets Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Modafinil Tablets Market Value (USD Million) By Region

Table 10: Global Modafinil Tablets Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Modafinil Tablets Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Modafinil Tablets Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Modafinil Tablets Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Cephalon Basic Information And Sales Area

Table 31: Cephalon. Products Portfolio

Table 32: Aurobindo Pharma Basic Information And Sales Area

Table 33: Aurobindo Pharma. Products Portfolio

Table 34: Apotex Basic Information And Sales Area

Table 35: Apotex. Products Portfolio

Table 36: Sun Pharmaceutical Basic Information And Sales Area

Table 37: Sun Pharmaceutical. Products Portfolio

Table 38: Watson Labs Basic Information And Sales Area

Table 39: Watson Labs. Products Portfolio

Table 40: Orbion Pharmaceuticals Basic Information And Sales Area

Table 41: Orbion Pharmaceuticals. Products Portfolio

Table 42: Zydus Basic Information And Sales Area

Table 43: Zydus. Products Portfolio

Table 44: Alembic Pharma Basic Information And Sales Area

Table 45: Alembic Pharma. Products Portfolio

Table 46: Global Market Value (USD Million) (2025-2032) By Application

Table 47: Global Market Share (%) By Application (2032)

Table 48: Global Market Value (USD Million) (2025-2032) By Types

Table 49: Global Market Share (%) By Types (2032)

Table 50: Global Modafinil Tablets Market Value (USD Million) By Region

Table 51: Global Modafinil Tablets Market Share (%) By Region (2025-2032)

Table 52: North America Market Value (USD Million) (2025-2032) By Country

Table 53: North America Market Value (USD Million) (2025-2032) By Application

Table 54: North America Market Value (USD Million) (2025-2032) By Types

Table 55: Europe Market Value (USD Million) (2025-2032) By Country

Table 56: Europe Market Value (USD Million) (2025-2032) By Application

Table 57: Europe Market Value (USD Million) (2025-2032) By Types

Table 58: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 59: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 60: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 61: South America Market Value (USD Million) (2025-2032) By Country

Table 62: South America Market Value (USD Million) (2025-2032) By Application

Table 63: South America Market Value (USD Million) (2025-2032) By Types

Table 64: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 65: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 66: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 67: Research Programs/Design For This Report

Table 68: Key Data Information From Secondary Sources

Table 69: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Modafinil Tablets Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.67 billion
Growth rate	CAGR of 4.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Cephalon; Aurobindo Pharma; Apotex; Sun Pharmaceutical; Watson Labs; Orbion Pharmaceuticals; Zydus; Alembic Pharma
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options